期刊文献+

老年男性糖尿病患者骨质疏松与动脉硬化的相关性研究 被引量:7

Correlation between atherosclerosis and osteoporosis in elderly male patients with type 2diabetes
下载PDF
导出
摘要 目的探讨老年男性糖尿病人群骨质疏松与动脉硬化的相关性。方法测定226例老年男性糖尿病患者的股骨近端骨密度(BMD),将其分为骨质疏松组和非骨质疏松组,分别比较两组的一般情况,同时采用动脉硬化检测仪测定其踝肱指数(ABI)和脉搏波传导速度(PWV)。结果骨质疏松组患者的吸烟比例较非骨质疏松组高,差异有显著性(P<0.05)。骨质疏松组患者的ABI显著低于非骨质疏松组,PWV高于骨质疏松组,两组比较差异有显著性(P<0.05)。随BMD水平下降,所有患者的PWV水平升高,ABI降低,提示动脉硬化程度加重。结论老年男性糖尿病骨质疏松患者更易并发动脉粥样硬化病变,治疗和预防时应采取系统性的措施。 Objective To study the relationship between atherosclerosis and osteoporosis in elderly male patients with type 2diabetes.Methods Bone mineral density(BMD) of the proximal femurs in 226 elderly male patients with type 2 diabetes was measured.The patients were divided into osteoporosis group and non-osteoporosis group.The general status between the two groups was compared.PWV and ABI were measured using an atherosclerosis detector.Results Percentage of smoking patients was significantly more in osteoporosis group than in non-osteoporosis group(P 0.05).ABI was significantly lower in osteoporosis patients than in non-osteoporosis patients(P 0.05).PWV was significantly higher in non-osteoporosis patients than in osteoporosis patients(P 0.05).With the decrease of BMD,PWV increased but ABI decreased in all patients,suggesting the severity of atherosclerosis.Conclusion Elderly male patients with type 2 diabetes and osteoporosis may be easier to combine with atherosclerosis.Systematic treatment an prevention should be applied.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2014年第10期1219-1221,共3页 Chinese Journal of Osteoporosis
关键词 骨质疏松 动脉粥样硬化 老年男性 2型糖尿病 Osteoporosis Atherosclerosis Elderly male Type 2 diabetes
  • 相关文献

参考文献1

二级参考文献25

  • 1张永红,温进坤,韩梅.抗骨桥蛋白抗体防治大鼠动脉粥样硬化的研究[J].中国老年学杂志,2007,27(1):38-40. 被引量:4
  • 2方欣,管思明.骨桥蛋白与高血压血管重构[J].心脏杂志,2007,19(2):232-233. 被引量:7
  • 3Verhaar HJ. Medical treatment of osteoporosis in the elderly.Aging Clin Exp Res, 2009,21(6) : 407413.
  • 4Rodrigues LR, Teixeira JA, Schmitt FL, et al. The role ofosteopontin in tumor progression and metastasis in breast cancer.Cancer Epidemiol Biomarkers Prev,2007,16(6) ; 1087-1097.
  • 5Franzen Heinegard D. Isolation and characterization of twosialoproteins present only in bone ealcif-yed matrix. BiochemJ,1985,232(3) :715-724.
  • 6Jain SC,Akraboay G,Bulbule A,et al. Osteopontin: an emergingtherapeutic target for anticancer therapy. Expe Opin Ther Targets,2007,11(1) :81-90.
  • 7Philip Y,Wai Paul C,Kuo,et al. Osteopontin : regulation in tumormetastasis. Cancer Metastasis Rev,2008 ,27 ( 1 ) :103-118.
  • 8Rodrigues LR, Teixeira JA, Sehmitt FL, et al. The role ofosteopontin in tumor progression and metastasis in breast cancer.Cancer Epidemiol Biomarkers Prev,2007 ,16(6) :1087-1097.
  • 9Moil R,Shaw TJ,Martin P. Molecular mechanisms linking woundinflammation and fibrosis : knock down of osteopontin leads torapid repair and reduced scarring it. J Exp Med,2008 ,205 ( 1):43-51.
  • 10Chang PL, Harkins L,Hsieh YH,et al. Osteopontin expression innormal skin and non-melanoma skin tumom. J HistoehemCytochem,2008 ,56( 1 ) :57-66.

共引文献5

同被引文献69

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部